Armistice Capital Master Fund Ltd., 10% Owner at INNOVUS PHARMACEUTICALS, INC. (INNV), bought 18,183 shares at $2.65 ($47K) on 2019-09-17, disclosed to the SEC on 2019-09-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.48 | 9,183 | $23K | 48.8% |
| 2 | $2.65 | 9,000 | $24K | 51.2% |
| Total | $2.56 avg | 18,183 | $47K | 100% |
| Filing → |
| AVTX | BUY | 2022-01-11 | $1.1M | — | Filing → |
| AYTU | BUY | 2020-12-15 | $8.0M | — | Filing → |
| CERC | BUY | 2020-12-07 | $49K | — | Filing → |